載入...
Therapeutic targeting of immune checkpoints with small molecule inhibitors
Immune checkpoints are known to contribute to tumor progression by enhancing cancer’s ability to evade the immune system and metastasize. Immunotherapies, including monoclonal antibodies, have been developed to target specific immunosuppressive molecules on the membranes of cancer cells and have pro...
Na minha lista:
| 發表在: | Am J Transl Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
e-Century Publishing Corporation
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6413273/ https://ncbi.nlm.nih.gov/pubmed/30899360 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|